Syngene Thematic WP

News

Amgen and MediLink to collaborate on SCLC combination therapy

The companies will collaborate to hold a global Phase I combination trial of YL201 and Amgen’s Imdelltra for small cell lung cancer.

Frankie Fattorini

News

Piramal Pharma to expand Lexington sterile injectables facility in US

News

AstraZeneca/Daiichi’s ADC shows better survival for nonsquamous NSCLC patients

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

Amgen and MediLink to collaborate on SCLC combination therapy

Piramal Pharma to expand Lexington sterile injectables facility in US

AstraZeneca/Daiichi’s ADC shows better survival for nonsquamous NSCLC patients

Leading Strategic Intelligence Solutions for the Clinical Trials Industry

Key Lead Generation Providers and Technology Solutions for the Clinical Trials Industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing